RDF/XML JSON-LD N3/Turtle RDF/JSON
Author profile at the institutional portal

Quintela Fandiño, Miguel Angel miguel.quintela@uam.es

Medicina / Universidad Autónoma de Madrid

Publications

Targeting the Tumor Stroma in Breast Cancer

  • Sanchez-Ruiz J
  • Quintela-Fandino M

Current Breast Cancer Reports (p. 71-79) - 28/3/2015

10.1007/s12609-014-0173-9 View at source

  • ISSN 19434596

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

  • Bossuyt V
  • Provenzano E
  • Symmans WF
  • Boughey JC
  • Coles C
  • Curigliano G
  • Dixon JM
  • Esserman LJ
  • Fastner G
  • Kuehn T
  • Peintinger F
  • Von Minckwitz G
  • White J
  • Yang W
  • Badve S
  • Denkert C
  • MacGrogan G
  • Penault-Llorca F
  • Viale G
  • Cameron D
  • Davidson NE
  • Piccart M
  • Norton L
  • Earl H
  • Alba E
  • Lluch A
  • Albanell J
  • Amos K
  • Becette V
  • Biernat W
  • Bonnefoi H
  • Buzdar A
  • Cane P
  • Pinder S
  • Carson L
  • Dickson-Witmer D
  • Gong G
  • Green J
  • Hsu CY
  • Tseng LM
... View more Collapse

Annals Of Oncology (p. 1280-1291) - 1/7/2015

10.1093/annonc/mdv161 View at source

  • ISSN 09237534

Antiangiogenics and hypoxic response: Role of fatty acid synthase inhibitors

  • Bueno M
  • Sanchez J
  • Colomer R
  • Quintela-Fandino M

Current Drug Targets (p. 1735-1746) - 1/1/2016

10.2174/1389450117666160502151857 View at source

  • ISSN 13894501

Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality

  • Lord, Simon
  • Funes, Juan M.
  • Harris, Adrian L.
  • Quintela-Fandino, Miguel;

Current Drug Targets (p. 1714-1727) - 1/1/2016

10.2174/1389450117666160307143718 View at source

  • ISSN 13894501

Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer

  • Quintela-Fandino, Miguel
  • Ebos, John M. L.;

Current Drug Targets (p. 1706-1706) - 1/1/2016

10.2174/1389450117999160425123635 View at source

  • ISSN 13894501

Analysis of paired primary-metastatic hormone-receptor positive breast tumors (HRPBC) uncovers potential novel drivers of hormonal resistance

  • Manso L., Mourón S., Tress M., Gómez-López G., Morente M., Ciruelos E., Rubio-Camarillo M., Rodriguez-Peralto J.L., Pujana M.A., Pisano D.G., Quintela-Fandino M.

Plos One - 1/5/2016

10.1371/journal.pone.0155840

  • ISSN 19326203
  • iMarina
Open Access

Monitoring vascular normalization induced by antiangiogenic treatment with F-18-fluoromisonidazole-PET

  • Hernández Agudo, Elena
  • Mondejar, Tamara
  • Soto Montenegro, Mª Luisa
  • Megías, Diego
  • Mourón, Silvana
  • Sánchez, Jesús
  • Hidalgo, Manuel
  • López Casas, Pedro Pablo
  • Mulero, Francisca
  • Desco Menendez, Manuel
  • Quintela Fandino, Miguel
... View more Collapse

Molecular Oncology (p. 704-718) - 1/5/2016

10.1016/j.molonc.2015.12.011 View at source

  • ISSN 1878-0261

Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics

  • Navarro, P
  • Bueno, MJ
  • Zagorac, I
  • Mondejar, T
  • Sanchez, J
  • Mouron, S
  • Munoz, J
  • Gomez-Lopez, G
  • Jimenez-Renard, V
  • Mulero, F
  • Chandel, NS
  • Quintela-Fandino, M
... View more Collapse

Cell Reports (p. 2705-2718) - 21/6/2016

10.1016/j.celrep.2016.05.052 View at source

  • ISSN 22111247

Normoxic or hypoxic adaptation in response to antiangiogenic therapy: Clinical implications

  • Quintela-Fandino, M.;

Mol Cell Oncol - 2/9/2016

10.1080/23723556.2016.1217368 View at source

  • ISSN 23723556

Critically short telomeres and toxicity of chemotherapy in early breast cancer

  • Quintela-Fandino M
  • Soberon N
  • Lluch A
  • Manso L
  • Calvo I
  • Cortes J
  • Moreno-Antón F
  • Gil-Gil M
  • Martinez-Jánez N
  • Gonzalez-Martin A
  • Adrover E
  • de Andres R
  • Viñas G
  • Llombart-Cussac A
  • Alba E
  • Mouron S
  • Guerra J
  • Bermejo B
  • Zamora E
  • García-Saenz JA
  • Simon SP
  • Carrasco E
  • Escudero MJ
  • Campo R
  • Colomer R
  • Blasco MA
... View more Collapse

Oncotarget (p. 21472-21482) - 1/1/2017

10.18632/oncotarget.15592

  • ISSN 19492553
  • iMarina

This researcher has no books.

This researcher has no book chapters.

Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study

  • Quintela-Fandino, M.
  • Urruticoechea, A.
  • Guerra, J.
  • Gil, M.
  • Gonzalez-Martin, A.
  • Marquez, R.
  • Hernandez-Agudo, E.
  • Rodriguez-Martin, C.
  • Gil, M.
  • Bratos, R.
  • Escudero, M. J.
  • Colomer, R.;
... View more Collapse

Cancer Research - 15/12/2013

10.1158/0008-5472.sabcs13-pd5-8 View at source

  • ISSN 00085472

This researcher has no working papers.

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors

  • Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR

Clinical Cancer Research (p. 2257-2269) - 1/1/2022

10.1158/1078-0432.ccr-21-3087 View at source

  • ISSN 15573265

This researcher has no research projects.

Triple negative breast cancer kinome-taxonomy, prognostic and therapeutics: role of polynucleotide kinase-phosphatase

  • QUINTELA FANDIÑO, MIGUEL ANGEL (Director) Doctorando: Fernández Gaitero, Sara

4/3/2021

  • iMarina

This researcher has no patents or software licenses.

Last data update: 3/18/24 2:43 PM